Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B Lymphocyte Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06343376
What this trial is testing

Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic Malignancies

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+11 more
Roswell Park Cancer Institute 1
Testing effectiveness (Phase 2)UnknownNCT02965092
What this trial is testing

CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell Lymphoma
Wuhan Sian Medical Technology Co., Ltd 80
Testing effectiveness (Phase 2)UnknownNCT05651100
What this trial is testing

Safety and Efficacy of Sequential CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Kecellitics Biotech Company Ltd 50
Large-scale testing (Phase 3)Looking for participantsNCT07621809
What this trial is testing

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

Who this might be right for
Sjögren´s Disease
Novartis Pharmaceuticals 570
Not applicableTemporarily pausedNCT03229876
What this trial is testing

Safety and Efficacy Evaluation of CD19-UCART

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Non Hodgkin Lymphoma (NHL)
Bioray Laboratories 20
Early research (Phase 1)Looking for participantsNCT07075185
What this trial is testing

Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMyeloma MultipleMultiple Myeloma Progression+11 more
Kelonia Therapeutics, Inc. 70
Testing effectiveness (Phase 2)UnknownNCT04089215
What this trial is testing

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinDiffuse Large B Cell LymphomaFollicular Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd. 82
Testing effectiveness (Phase 2)Ended earlyNCT03954106
What this trial is testing

A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity

Who this might be right for
DLBCLNeurotoxicity Syndromes
Jazz Pharmaceuticals 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03642626
What this trial is testing

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaLarge B-cell Lymphoma
Masonic Cancer Center, University of Minnesota 150
Early research (Phase 1)Ended earlyNCT04160195
What this trial is testing

T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma

Who this might be right for
Lymphoma, B-CellLymphoma, Non-hodgkinsChronic Lymphocytic Leukemia+1 more
National Cancer Institute (NCI) 2
Not applicableLooking for participantsNCT06355739
What this trial is testing

CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

Who this might be right for
B Lymphocytic LeukemiaB Lymphoblastic Lymphoma
Zhu Xiaofan 60
Early research (Phase 1)Active Not RecruitingNCT05797233
What this trial is testing

Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaB-Cell Chronic Lymphocytic LeukemiaLymphoma, B-Cell
National Cancer Institute (NCI) 58
Early research (Phase 1)UnknownNCT02842138
What this trial is testing

Autologous CD19 CAR T Cells in Relapsed or Refractory B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
Peking University 25
Early research (Phase 1)UnknownNCT04007978
What this trial is testing

Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell Malignancies

Who this might be right for
B Cell LymphomaAcute Lymphoblastic Leukemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Early research (Phase 1)Study completedNCT03049449
What this trial is testing

T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas

Who this might be right for
Lymphoma, Large-Cell, AnaplasticEnteropathy-Associated T-Cell LymphomaLymphoma, Large B-Cell, Diffuse+2 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Looking for participantsNCT06462248
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies

Who this might be right for
Lymphoma, NonhodgkinLeukemia, Lymphocytic
Chi Kong Li 20
Not applicableUnknownNCT03794115
What this trial is testing

Immune Repertoire of Ovarian HGSC

Who this might be right for
Ovarian High Grade Serous CarcinomaImmune RepertoireT Lymphocyte Receptor+1 more
Lei Li 40
Not applicableActive Not RecruitingNCT03047746
What this trial is testing

Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF

Who this might be right for
Acquired Aplastic AnemiaParoxysmal Nocturnal HemoglobinuriaInherited Bone Marrow Failure Syndromes
Children's Hospital of Philadelphia 50
Very early researchLooking for participantsNCT06446128
What this trial is testing

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Who this might be right for
Non-Hodgkin Lymphoma, B-cell
Shanghai Cell Therapy Group Co.,Ltd 20
Not applicableNot Yet RecruitingNCT07346820
What this trial is testing

VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation

Who this might be right for
Stem Cell Transplantation, HematopoieticV(D)J RecombinationReceptors, Antigen, B-Cel
Umeå University 65
Next Page